All Thayer Events
Optional ZOOM LINK
Derisking Medical Technology Commercialization from Idea to Clinical Use
3:30pm - 4:30pm EST
Spanos Auditorium / Zoom
Optional ZOOM LINK
Meeting ID: 983 6312 5452
Medical technology development and commercialization is a process driven by creativity, focus, and perseverance. Despite a wide range of technologies and fields of application, there are many common threads that are core elements of successful medical product development. Technological considerations are only one aspect of the equation but tend to monopolize the time and attention of many MedTech innovators. Successful translation from 'bench to bedside' often requires a holistic perspective. The ability to learn from mistakes and pivot toward potential is a transferable entrepreneurial skill that can be leveraged broadly. The first part of the presentation focuses on first-hand experiences and lessons learned from developing medical technology products and building a design and development company. The second part of the discussion shares a series of observations on medical technology commercialization that should resonate with those who are working to bring their medical product idea to market and clinical use.
About the Speaker(s)
Co-Founder & President of Simbex, Adjunct Professor of Engineering at Dartmouth
Professor Greenwald is an entrepreneur and biomedical engineer. He is co-founder and president of Simbex, co-founder of iWalk (BionX, sold to Otto Bock), and co-founder and executive director of the non-profit National Institute for Sports Science and Safety. He has led two federally-funded medical technology commercialization centers as co-director of the NIH-funded Center for Translation of Rehabilitation Engineering Advances and Technology (TREAT), a national rehabilitation infrastructure resource, and co-director of the previously FDA-funded New England Pediatric Device Consortium (NEPDC). Greenwald's research interests include biomechanics, injury prevention, sports equipment, product development, and technology commercialization. He is a Fellow of the National Academy of Inventors (NAI) and the American Institute of Medical and Biological Engineering (AIMBE), and also served as President of the International Society for Skiing Safety. He holds 22 US patents, with 3 patents pending.
For more information, contact Ashley Parker at firstname.lastname@example.org.